Prognostic impact of monocyte count at presentation in mantle cell lymphoma

被引:11
作者
George, Anupkumar [1 ]
Prince, Henry Miles [1 ,2 ]
Szer, Jeff [3 ]
Wolf, Max [1 ,2 ]
Januszewicz, Elchanan H. [1 ]
Seymour, John F. [1 ,2 ]
Ritchie, David S. [1 ,2 ,3 ]
机构
[1] Peter MacCallum Canc Ctr, Div Canc Med, Melbourne, Vic, Australia
[2] Univ Melbourne, Melbourne, Vic, Australia
[3] Royal Melbourne Hosp, Bone Marrow Transplant Serv, Melbourne, Vic, Australia
关键词
lymphoma; mantle cell lymphoma; monocytes; transplant; hyper-CVAD; FREE SURVIVAL; FOLLOW-UP; IMMUNOCHEMOTHERAPY; TRANSPLANTATION;
D O I
10.1111/bjh.12683
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:890 / 893
页数:4
相关论文
共 10 条
[1]   Immunochemotherapy and Autologous Stem-Cell Transplantation for Untreated Patients With Mantle-Cell Lymphoma: CALGB 59909 [J].
Damon, Lloyd E. ;
Johnson, Jeffrey L. ;
Niedzwiecki, Donna ;
Cheson, Bruce D. ;
Hurd, David D. ;
Bartlett, Nancy L. ;
LaCasce, Ann S. ;
Blum, Kristie A. ;
Byrd, John C. ;
Kelly, Michael ;
Stock, Wendy ;
Linker, Charles A. ;
Canellos, George P. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (36) :6101-6108
[2]   Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue:: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group [J].
Geisler, Christian H. ;
Kolstad, Arne ;
Laurell, Anna ;
Andersen, Niels S. ;
Pedersen, Lone B. ;
Jerkeman, Mats ;
Eriksson, Mikael ;
Nordstrom, Marie ;
Kimby, Eva ;
Boesen, Anne Marie ;
Kuittinen, Outi ;
Lauritzsen, Grete F. ;
Nilsson-Ehle, Herman ;
Ralfkiaer, Elisabeth ;
Akerman, Mans ;
Ehinger, Mats ;
Sundstrom, Christer ;
Langholm, Ruth ;
Delabie, Jan ;
Karjalainen-Lindsberg, Marja-Liisa ;
Brown, Peter ;
Elonen, Erkki .
BLOOD, 2008, 112 (07) :2687-2693
[3]   Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC plus autologous stem-cell support: still very long survival but late relapses do occur [J].
Geisler, Christian H. ;
Kolstad, Arne ;
Laurell, Anna ;
Jerkeman, Mats ;
Raty, Riikka ;
Andersen, Niels S. ;
Pedersen, Lone B. ;
Eriksson, Mikael ;
Nordstrom, Marie ;
Kimby, Eva ;
Bentzen, Hans ;
Kuittinen, Outi ;
Lauritzsen, Grete F. ;
Nilsson-Ehle, Herman ;
Ralfkiaer, Elisabeth ;
Ehinger, Mats ;
Sundstrom, Christer ;
Delabie, Jan ;
Karjalainen-Lindsberg, Marja-Liisa ;
Brown, Peter ;
Elonen, Erkki .
BRITISH JOURNAL OF HAEMATOLOGY, 2012, 158 (03) :355-362
[4]   A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma [J].
Hoster, Eva ;
Dreyling, Martin ;
Klapper, Wolfram ;
Gisselbrecht, Christian ;
van Hoof, Achiel ;
Kluin-Nelemans, Hanneke C. ;
Pfreundschuh, Michael ;
Reiser, Marcel ;
Metzner, Bernd ;
Einsele, Hermann ;
Peter, Norma ;
Jung, Wolfram ;
Woermann, Bernhard ;
Ludwig, Wolf-Dieter ;
Duehrsen, Ulrich ;
Eimermacher, Hartmut ;
Wandt, Hannes ;
Hasford, Joerg ;
Hiddemann, Wolfgang ;
Unterhalt, Michael .
BLOOD, 2008, 111 (02) :558-565
[5]   Immunosuppressive CD14+HLA-DRlow/- monocytes in B-cell non-Hodgkin lymphoma [J].
Lin, Yi ;
Gustafson, Michael P. ;
Bulur, Peggy A. ;
Gastineau, Dennis A. ;
Witzig, Thomas E. ;
Dietz, Allan B. .
BLOOD, 2011, 117 (03) :872-881
[6]   Peripheral blood absolute lymphocyte/monocyte ratio recovery during ABVD treatment cycles predicts clinical outcomes in classical Hodgkin lymphoma [J].
Porrata, L. F. ;
Ristow, K. M. ;
Habermann, T. M. ;
Macon, W. R. ;
Witzig, T. E. ;
Colgan, J. P. ;
Inwards, D. J. ;
Ansell, S. M. ;
Micallef, I. N. ;
Johnston, P. B. ;
Nowakowski, G. ;
Thompson, C. A. ;
Markovic, S. N. .
BLOOD CANCER JOURNAL, 2013, 3 :e110-e110
[7]   The hyper-CVAD-rituximab chemotherapy programme followed by high-dose busulfan, melphalan and autologous stem cell transplantation produces excellent event-free survival in patients with previously untreated mantle cell lymphoma [J].
Ritchie, D. S. ;
Seymour, J. F. ;
Grigg, A. P. ;
Roberts, A. W. ;
Hoyt, R. ;
Thompson, S. ;
Szer, J. ;
Prince, H. M. .
ANNALS OF HEMATOLOGY, 2007, 86 (02) :101-105
[8]   Ten-year follow-up after intense chemoimmunotherapy with Rituximab-HyperCVAD alternating with Rituximab-high dose methotrexate/cytarabine (R-MA) and without stem cell transplantation in patients with untreated aggressive mantle cell lymphoma [J].
Romaguera, Jorge E. ;
Fayad, Luis E. ;
Feng, Lei ;
Hartig, Kimberly ;
Weaver, Pamela ;
Rodriguez, Maria Alma ;
Hagemeister, Fredrick B. ;
Pro, Barbara ;
McLaughlin, Peter ;
Younes, Anas ;
Samaniego, Felipe ;
Goy, Andre ;
Cabanillas, Fernando ;
Kantarjian, Hagop ;
Kwak, Larry ;
Wang, Michael .
BRITISH JOURNAL OF HAEMATOLOGY, 2010, 150 (02) :200-208
[9]   Prognostic impact of monocyte count at presentation in mantle cell lymphoma [J].
von Hohenstaufen, Kathrin Aprile ;
Conconi, Annarita ;
de Campos, Cassio Polpo ;
Franceschetti, Silvia ;
Bertoni, Francesco ;
Casaluci, Gloria Margiotta ;
Stathis, Anastasios ;
Ghielmini, Michele ;
Stussi, Georg ;
Cavalli, Franco ;
Gaidano, Gianluca ;
Zucca, Emanuele .
BRITISH JOURNAL OF HAEMATOLOGY, 2013, 162 (04) :465-473
[10]   Absolute monocyte count in follicular lymphoma patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone [J].
Watanabe, Reina ;
Tomita, Naoto ;
Kishimoto, Kumiko ;
Koyama, Satoshi ;
Ogusa, Eriko ;
Ishii, Yoshimi ;
Miyashita, Kazuho ;
Matsuura, Shiro ;
Fujisawa, Shin ;
Hattori, Yukako ;
Takasaki, Hirotaka ;
Fujita, Atsuko ;
Ohshima, Rika ;
Kuwabara, Hideyuki ;
Hashimoto, Chizuko ;
Fujimaki, Katsumichi ;
Sakai, Rika ;
Ishigatsubo, Yoshiaki .
LEUKEMIA RESEARCH, 2013, 37 (10) :1208-1212